RRC ID 44392
Author Fukuda Y, Kanbe M, Watanabe M, Dan K, Matsuzaki K, Kitanaka S, Miyata S.
Title 3EZ,20Ac-ingenol, a catalytic inhibitor of topoisomerases, downregulates p-Akt and induces DSBs and apoptosis of DT40 cells.
Journal Arch Pharm Res
Abstract We have previously reported that many ingenol compounds derived from Euphorbia kansui exhibit topoisomerase (topo) II inhibitory activity. Of these compounds, 3EZ,20Ac-ingenol inhibited topo I activity. Camptothecin, which inhibits the religation activity of topo I without interfering with the binding of topo I to DNA and induces topo I-mediated DNA cleavage, was used as a positive control. In this study, we found that 3EZ,20Ac-ingenol did not hamper the binding of topo I to DNA in the same manner as camptothecin but affected the inhibition of cleavage of one DNA strand. 3EZ,20Ac-ingenol inhibited cell proliferation by blocking cell cycle progression in the G2/M phase. To define the mechanism of inhibition of DT40 cell proliferation, the change in Akt activity was observed because Akt activity is regulated in response to DNA damage. Western blot analysis revealed that 3EZ,20Ac-ingenol downregulated the expression of p-Akt, and apoptosis was detected by the presence of DNA double-strand breaks and caspase 3 activation.
Volume 36(8)
Pages 1029-38
Published 2013-8-1
DOI 10.1007/s12272-013-0108-4
PMID 23595550
PMC PMC3731510
MeSH Animals Apoptosis / drug effects* Apoptosis / physiology Catalysis Cell Proliferation / drug effects Chickens DNA Breaks, Double-Stranded / drug effects* Diterpenes / chemistry Diterpenes / pharmacology* Dose-Response Relationship, Drug Down-Regulation / drug effects* Down-Regulation / physiology Proto-Oncogene Proteins c-akt / antagonists & inhibitors* Proto-Oncogene Proteins c-akt / metabolism Topoisomerase Inhibitors / chemistry Topoisomerase Inhibitors / pharmacology*
IF 2.934
Times Cited 7
WOS Category PHARMACOLOGY & PHARMACY CHEMISTRY, MEDICINAL
Resource
Human and Animal Cells DT40(RCB1464) ΔBLM-DT40(RCB1811) ΔWRN-DT40(RCB1812)